We are pleased to announce that Lifang has been recognized as a leading patent law firm in the prestigious rankings IAM Patent 1000 2025, published by Intellectual Asset Management. Lifang has been awarded Gold for litigation, Bronze for prosecution, and a Recommended ranking for transactions in China. Additionally, six of our partners—Xie Guanbin, Yu Haidong, Wu Li, Zhang Yuanyuan, Xu Manxia, and Wang Ying—have been honored as leading patent attorneys.

Since 2013, Lifang has consistently been featured in the IAM Patent 1000, underscoring the firm's exceptional expertise in patent law. We are committed to building on this recognition and continuing to achieve new successes in the field of patent law.

Ranked areas

Gold - Firms: litigation

Bronze - Firms: prosecution

Recommended - Firms: transactions

Ranked attorneys

XIE Guanbin: Gold - Individuals: litigation

Consummate litigator Guanbin Xie “is a very experienced and capable strategist who spearheads a bunch of capable partners to handle complicated matters”, enthuses a client.

YU Haidong: Silver - Individuals: litigation / Silver - Individuals: prosecution

The firm is no stranger to landmark cases in front of the Supreme People’s Court and the Beijing IP Court – credit in this regard should be given to all-rounder Haidong Yu. 

WU Li: Silver - Individuals: prosecution

Doctorate Li Wu has been entrusted by pharmaceutical behemoth Sinopec to streamline its multi-jurisdictional transactions, thanks to his stint practising in the United States. 

ZHANG Yuanyuan: Bronze - Individuals: litigation

Yuanyuan Zhang is adept at prioritising clients’ business interests, leveraging her top technical credentials to calibrate the best approach to telecommunications and software disputes. 

XU Manxia: Bronze - Individuals: litigation

Manxia Xu excels in providing solid solutions and consultations to cases spanning almost all technological fields, namely machinery, electronics and automotive.

WANG Ying: Recommended - Individuals: transactions

Ying Wang's transactional capability can be matched by only a few in the market – given her tenure as legal counsel to a wide array of biopharmaceutical companies.